Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Methotrexate-D3 Solution, 100 μg/mL in Methanol with 0.01N NaOH, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco M1531ML
Description
An internal standard suitable for therapeutic drug monitoring analyses of methotrexate patient serum samples by LC-MS/MS. Used in the treatment of cancer and autoimmune diseases, methotrexate is an antimetabolite and antifolate drug monitored by clinical labs to ensure patients remain within the drug's therapeutic range. The Snap-N-Spike™ solution format allows laboratories to eliminate weighing operations of hazardous substances such as methotrexate, significantly reducing occupational exposure hazards related to handling of acutely toxic powders, and provides the ability to spike into their matrix of choice just before use.
Specifications
| 67-56-1, 432545-63-6 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 457.46 | |
| 1 mL |
| C20H19N8O5D3 | |
| 100 μg/mL in methanol with 0.01N NaOH | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?Share a Content Correction